Clinical trial
Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children
NCT00102817 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00102817 |
|---|---|
| Title | Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children |
| Official title | Somatropin (Norditropin) in Children With Growth Failure Associated With ICF Deficiency. |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Growth Hormone Disorder, Pituitary Dwarfism |
| Intervention type | Drug |
| Interventions | somatropin |
| Enrollment | 149 |
| Start date | May 1, 2003 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Feb 2, 2005 |
| Last update posted | Jan 18, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: